Is HIV testing during labor feasible?

February 27, 2009

Cameroon is a sub-Saharan African country with high HIV rates yet many pregnant women do not know their HIV status. Research published in the open access journal BMC Pregnancy and Childbirth has shown that HIV testing during labour is a suitable way of improving detection rates and may help mothers and their infants receive appropriate antiretroviral treatment.

Eugene Kongnyuy of the Liverpool School of Tropical Medicine and his collaborators from the University of Yaounde I, Cameroon, investigated the acceptability of rapid HIV testing among 2413 women of unknown HIV status at four hospitals in the capital city, Yaounde. They found that 88.3% of the women were willing to accept HIV testing during labour. Furthermore, their study revealed a higher rate of HIV infection among women screened during labour (10.1%) than was previously estimated in a national health survey (6.8%) which, according to the authors, highlights the importance of HIV testing during labour.

About 3.2 million infants and young children worldwide are infected with HIV and in most cases the infection is a consequence of mother-to-child transmission (MTCT). Rapid HIV testing during labour or delivery represents the last opportunity for treatment before delivery to reduce MTCT. While this investigation has shown that HIV testing in the delivery room is feasible, it is nevertheless a challenging task especially in resource-constraint settings. The authors recommend "an opt-out approach for HIV testing during labour in Cameroon (i.e. women are informed that HIV testing will be routine during labour if HIV status is unknown but each person may decline to be tested). Such an approach will decrease the proportion of women who give birth with unknown HIV status and increase the number of mother-infant pairs who receive appropriate treatment for preventing MTCT of HIV".

The team propose that cost-effectiveness of HIV counselling and testing during labour is evaluated before the approach is implemented nationwide.

More information: Acceptability of intrapartum HIV counselling and testing in Cameroon, Eugene Kongnyuy, Enow Mbu, Francois Mbopi-Keou, Nelson Fomulu, Philip Nana, Pierre Tebeu, Rebecca Tonye and Robert Leke, BMC Pregnancy and Childbirth (in press), http://www.biomedcentral.com/bmcpregnancychildbirth/

Source: BioMed Central


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - not rated yet


February 27, 2009 all stories

Comments: 0

not rated yet
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

Other News

Scientists reveal 'protector' gene behind 50-fold increase in number of bowel tumours

Medicine & Health / Cancer

created 12 minutes ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Cancer Research UK scientists have shown that deleting a single gene can increase the average number of tumours in the bowel by 50-fold, according to research published in PNAS today.


An end to sleep problems? Researchers discover enzyme behind effects of sleep deprivation

Medicine & Health / Research

created 1hour ago | popularity not rated yet | comments 0

There is hope for those who miss one night too many or whose children keep them up at night. The unwelcome effects of a bad night's sleep - forgetfulness, impaired mental performance - can be dealt with by reducing the concentration ...


Ginkgo biloba doesn’t prevent cardiovascular events but may have potential peripheral artery disease benefits

Medicine & Health / Research

created 1hour ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Ginkgo biloba didn’t prevent cardiovascular death or major events such as heart attack and stroke in people age 75 and older, but the herb may affect peripheral vascular disease, according to research reported ...


Implant-based cancer vaccine is first to eliminate tumors in mice

Implant-based cancer vaccine is first to eliminate tumors in mice

Medicine & Health / Cancer

created 20 hours ago | popularity 4.7 / 5 (22) | comments 4

(PhysOrg.com) -- A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal ...


Brain's endocannabinoid signaling pathway kept in check by two enzymes

Medicine & Health / Research

created 17 hours ago | popularity 4 / 5 (4) | comments 1

(PhysOrg.com) -- A research team has shown that blocking the degradation of two naturally occurring cannabinoids in the endocannabinoid signaling pathway of the brain produces marijuana-like behavioral effects in mice, according ...